Evercore ISI Boosts Welltower (NYSE:WELL) Price Target to $114.00

Welltower (NYSE:WELL) had its price objective hoisted by research analysts at Evercore ISI from $106.00 to $114.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “in-line” rating on the real estate investment trust’s stock. Evercore ISI’s price objective suggests a potential downside of 11.89% from the company’s previous close.

Several other research analysts have also recently issued reports on the company. Wells Fargo & Company increased their price objective on Welltower from $107.00 to $111.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Royal Bank of Canada raised their price target on Welltower from $101.00 to $114.00 and gave the company a “sector perform” rating in a research note on Friday, August 9th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Welltower from $115.00 to $137.00 and gave the stock a “buy” rating in a report on Wednesday, August 21st. Wedbush upped their price target on shares of Welltower from $100.00 to $120.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Finally, Scotiabank upped their target price on Welltower from $116.00 to $121.00 and gave the stock a “sector outperform” rating in a report on Wednesday, August 7th. Four analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Welltower presently has a consensus rating of “Moderate Buy” and an average price target of $112.38.

Welltower Trading Down 0.3 %

WELL traded down $0.37 during trading hours on Monday, reaching $129.38. 523,764 shares of the company’s stock traded hands, compared to its average volume of 2,691,891. The firm has a 50-day moving average price of $115.29 and a 200 day moving average price of $103.55. The firm has a market capitalization of $78.81 billion, a PE ratio of 159.72, a PEG ratio of 2.97 and a beta of 1.21. The company has a quick ratio of 4.07, a current ratio of 4.07 and a debt-to-equity ratio of 0.47. Welltower has a 52-week low of $78.38 and a 52-week high of $131.20.

Welltower (NYSE:WELL) last announced its quarterly earnings data on Monday, July 29th. The real estate investment trust reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.08. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.89 billion. Welltower had a net margin of 8.36% and a return on equity of 2.21%. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $0.90 EPS. As a group, sell-side analysts predict that Welltower will post 4.19 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in WELL. First Foundation Advisors purchased a new position in Welltower in the 2nd quarter worth $26,000. Rise Advisors LLC acquired a new stake in Welltower during the first quarter valued at $27,000. TruNorth Capital Management LLC purchased a new position in Welltower in the second quarter valued at $27,000. Meeder Asset Management Inc. acquired a new position in shares of Welltower in the second quarter worth about $30,000. Finally, Manchester Capital Management LLC boosted its stake in shares of Welltower by 338.7% during the 1st quarter. Manchester Capital Management LLC now owns 329 shares of the real estate investment trust’s stock worth $31,000 after acquiring an additional 254 shares in the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Welltower Company Profile

Welltower Inc (NYSE:WELL), a REIT and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.